Honeysuckle Health and nib

Summary

Honeysuckle Health Pty Ltd (HH) and nib health funds ltd (together, the Applicants) are seeking authorisation for ten years for HH to form and operate a buying group to collectively negotiate and administer contracts with healthcare providers (including hospitals, medical specialists, general practitioners and allied health professionals) on behalf of participants. The participants of the HH buying group may include private health insurers, international medical and travel insurance companies, government and semi-government payers of health care services, and any other payer of health services as notified by HH to the ACCC.

HH is an equal joint venture between nib health funds ltd and Cigna Corporation, a global health services company.

 The ACCC invites submissions from interested parties in relation to the application by 5 February 2021. Details on how to make a submission are available below, along with a copy of the application.

 

An indicative timetable is set out below for your information.

Indicative date 

Stage in assessment process 

24 December 2020 

Lodgement of application and supporting submission. 

12 January 2021 

Public consultation process begins. 

5 February 2021

Closing date for submissions from interested parties.

February 2021

Applicants respond to issues raised in submissions.

March/April 2021 

Draft determination. 

March/April 2021

Public consultation on draft determination including any conference if called.

April/May 2021

Final determination.

Applicant(s)

  • Honeysuckle Health Pty Ltd
  • nib health funds limited

Authorisation number(s)

  • AA1000542-1

Applications

Consultations

Submissions - before draft decision

Document title Date